Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trop2-targeted immunoPET Imaging of Solid Tumors
NCT06851663Phase 3Recruiting
- Sponsor
- Renji Hospital
- Start
- Dec 2024
- Primary completion
- Dec 2027
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Nanobodies (VHH)
- Countries
- 1
01
Overview
A Phase 3 trial of [68Ga]Ga-NOTA-T4, [68Ga]Ga-NOTA-RT4, [18F]AlF-RESCA-T4, [18F]F-RESCA-RT4 in solid tumor, sponsored by Renji Hospital. Started Dec 2024; status: recruiting.
02
Drugs
[68Ga]Ga-NOTA-T4[68Ga]Ga-NOTA-RT4[18F]AlF-RESCA-T4[18F]F-RESCA-RT4
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT06851663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06851663.